Comparison of two toxins produced by Clostridium difficile.

Infection and Immunity
N S TaylorJ G Bartlett

Abstract

Clostridium difficile was shown to produce a toxin which could be biochemically separated from the previously described cytotoxin of the same organism. The two proteins differ in biological activity and physical properties. Antiserum prepared to the second toxin does not neutralize the biological activity of the cytotoxin, and immunological cross-reactivity could not be demonstrated. However, some relationship may exist between the two toxins, since the newly described toxin degrades on polyacrylamide electrophoresis into two molecules, one of which appears to migrate with the band of purified cytotoxin. We suggest that this newly described toxin be designated toxin A until its primary biological activity and physical relationship to cytotoxin is determined. This toxin is active in biological assays of enteric disease and may play an important role in C. difficile-induced colitis.

References

Dec 24, 1977·Lancet·H E Larson, A B Price
May 20, 1978·Lancet·H E LarsonS P Borriello
Apr 15, 1978·Lancet·W L GeorgeS M Finegold
Jul 1, 1979·Infection and Immunity·R D Rolfe, S M Finegold
Mar 1, 1979·Reviews of Infectious Diseases·N S Taylor, J G Bartlett
Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
Mar 18, 1978·British Medical Journal·R H GeorgeD W Burdon
Nov 1, 1977·The Journal of Infectious Diseases·J G BartlettD L Kasper
Jul 1, 1974·Analytical Biochemistry·S C MarchP Cuatrecasas
Jun 1, 1980·Infection and Immunity·M EhrichT D Wilkins
Dec 28, 1964·Annals of the New York Academy of Sciences·B J DAVIS

❮ Previous
Next ❯

Citations

May 1, 1992·Molecular & General Genetics : MGG·C von Eichel-StreiberM Sauerborn
Jan 1, 1986·Critical Reviews in Clinical Laboratory Sciences·R D Rolfe
Jan 1, 1983·Microbiology and Immunology·K YamakawaS Nakamura
Dec 26, 2009·Journal of Intensive Care Medicine·Marc-André LeclairJacques Pépin
Jul 1, 2010·Toxins·Xingmin SunHanping Feng
May 5, 2012·Gut Microbes·Emma L BestMark H Wilcox
Feb 1, 1991·Cytotechnology·M Thelestam
Jun 1, 1995·Critical Care Medicine·W Chatila, C A Manthous
Jan 1, 1982·Microbiology and Immunology·S NakamuraS Nishida
Jan 12, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Marwan S AbougergiBernard G Jaar
Nov 8, 2007·Digestive Diseases and Sciences·Crystianne Calado LimaJosé Henrique Leal-Cardoso
Dec 22, 2009·Organic & Biomolecular Chemistry·Ping ZhangChang-Chun Ling
Mar 1, 2012·Molecular Microbiology·Jordi M LanisJimmy D Ballard
Oct 12, 2010·Expert Review of Gastroenterology & Hepatology·Ashwin N Ananthakrishnan, David G Binion
Jul 21, 2015·Hospital Practice·Lokesh Shahani, Janak Koirala
Aug 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R A Bowman, T V Riley
Jan 1, 1988·Microbiology and Immunology·T KatohT Miwatani
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Catherine McEllistremL Zheng
May 5, 2006·Veterinary Pathology·M K Keel, J G Songer
Dec 3, 2005·The New England Journal of Medicine·L Clifford McDonaldDale N Gerding
Jul 13, 2006·FEMS Immunology and Medical Microbiology·Anna WanahitaDaniel M Musher
Sep 15, 2011·Gastroenterology Research and Practice·Preetika SinhLaura Yun
Aug 26, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sherwood L Gorbach
Dec 24, 2010·Annals of the New York Academy of Sciences·John G Bartlett
Jun 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Tsimidis, A E Simor
Oct 22, 2003·Canadian Journal of Microbiology·S SimiT Yano
Dec 1, 1983·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·I Lönnroth, S Lange

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.